These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8458477)

  • 1. Acute urinary retention after gonadotropin-releasing hormone agonist treatment for leiomyomata uteri.
    Friedman AJ
    Fertil Steril; 1993 Mar; 59(3):677-8. PubMed ID: 8458477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective, randomized trial of gonadotropin-releasing hormone agonist plus estrogen-progestin or progestin "add-back" regimens for women with leiomyomata uteri.
    Friedman AJ; Daly M; Juneau-Norcross M; Rein MS; Fine C; Gleason R; Leboff M
    J Clin Endocrinol Metab; 1993 Jun; 76(6):1439-45. PubMed ID: 8501148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Massive ascites after leuprolide acetate administration for the treatment of leiomyomata uteri.
    Lee MJ; Kazer RR
    Fertil Steril; 1992 Aug; 58(2):416-8. PubMed ID: 1633912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance imaging of leiomyomata uteri: assessing therapy with the gonadotropin-releasing hormone agonist leuprolide.
    Lubich LM; Alderman MG; Ros PR
    Magn Reson Imaging; 1991; 9(3):331-4. PubMed ID: 1908932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of uterine volume reduction in women with myomas treated with a gonadotropin-releasing hormone agonist.
    Friedman AJ; Daly M; Juneau-Norcross M; Rein MS
    Fertil Steril; 1992 Aug; 58(2):413-5. PubMed ID: 1633911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gonadotropin-releasing hormone agonist use before hysterectomy.
    Stovall TG; Summit RL; Washburn SA; Ling FW
    Am J Obstet Gynecol; 1994 Jun; 170(6):1744-8; discussion 1748-51. PubMed ID: 8203435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of leiomyomata with intranasal or subcutaneous leuprolide, a gonadotropin-releasing hormone agonist.
    Friedman AJ; Barbieri RL; Benacerraf BR; Schiff I
    Fertil Steril; 1987 Oct; 48(4):560-4. PubMed ID: 3115833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Major hemorrhage in a patient with multiple submucous leiomyomata during the treatment of long-acting gonadotropin-releasing hormone agonist.
    Wang KC; Lee WL; Yuan CC; Wang PH
    Kaohsiung J Med Sci; 2000 Feb; 16(2):103-7. PubMed ID: 10816995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of a low-dose leuprolide acetate depot in the treatment of uterine leiomyomata in Japanese women.
    Watanabe Y; Nakamura G; Matsuguchi H; Nozaki M; Sano M; Nakano H
    Fertil Steril; 1992 Jul; 58(1):66-71. PubMed ID: 1624025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a gonadotropin-releasing hormone agonist to manage perimenopausal women with symptomatic uterine myomas.
    Wang PH; Lee WL; Cheng MH; Yen MS; Chao KC; Chao HT
    Taiwan J Obstet Gynecol; 2009 Jun; 48(2):133-7. PubMed ID: 19574174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute urinary retention caused by a uterine leiomyoma: a case report.
    Novi JM; Shaunik A; Mulvihill BH; Morgan MA
    J Reprod Med; 2004 Feb; 49(2):131-2. PubMed ID: 15018444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized trial evaluating leuprolide acetate before hysterectomy as treatment for leiomyomas.
    Stovall TG; Ling FW; Henry LC; Woodruff MR
    Am J Obstet Gynecol; 1991 Jun; 164(6 Pt 1):1420-3; discussion 1423-5. PubMed ID: 1904681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of leiomyomata uteri with short-term leuprolide followed by leuprolide plus estrogen-progestin hormone replacement therapy for 2 years: a pilot study.
    Friedman AJ
    Fertil Steril; 1989 Mar; 51(3):526-8. PubMed ID: 2537769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Submucous myomas treated with gonadotropin releasing hormone agonist and resulting in vaginal hemorrhage. A case report.
    Thorp JM; Katz VL
    J Reprod Med; 1991 Aug; 36(8):625-6. PubMed ID: 1941808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of gonadotropin-releasing hormone agonist treatment upon angiogenesis in uterine leiomyoma.
    Abulafia O; Kleinhaus K; Levi G; Lee YC; Sherer DM
    Gynecol Obstet Invest; 2001; 52(2):108-13. PubMed ID: 11586038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous expulsion of a uterine submucosal leiomyoma after administration of a gonadotropin-releasing hormone agonist.
    Yu KJ; Lai CR; Sheu MH
    Eur J Obstet Gynecol Reprod Biol; 2001 Jun; 96(2):223-5. PubMed ID: 11384814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of a gonadotropin-releasing hormone agonist in the treatment of uterine leiomyomata: long-term follow-up.
    Letterie GS; Coddington CC; Winkel CA; Shawker TH; Loriaux DL; Collins RL
    Fertil Steril; 1989 Jun; 51(6):951-6. PubMed ID: 2498132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Usefulness of GnRH agonists in preoperative treatment of complicated uterine myomata].
    Campusano C; Zapata R; Bianchi M; Badia JI; Arteaga E
    Rev Chil Obstet Ginecol; 1993; 58(2):150-4. PubMed ID: 8209044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effectiveness and safety of GnRH agonist plus raloxifene administration in women with uterine leiomyomas.
    Palomba S; Orio F; Russo T; Falbo A; Cascella T; Doldo P; Nappi C; Lombardi G; Mastrantonio P; Zullo F
    Hum Reprod; 2004 Jun; 19(6):1308-14. PubMed ID: 15117890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaginal expulsion of a submucosal myoma during treatment with long-acting gonadotropin-releasing hormone agonist.
    Wen L; Tseng JY; Wang PH
    Taiwan J Obstet Gynecol; 2006 Jun; 45(2):173-5. PubMed ID: 17197363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.